Literature DB >> 9799087

Variability in the serotonin transporter gene and increased risk for major depression with melancholia.

B Gutiérrez1, L Pintor, C Gastó, A Rosa, J Bertranpetit, E Vieta, L Fañanás.   

Abstract

The serotonin transporter (SERT) gene is a particularly interesting candidate for genetic involvement in affective disorders owing to its role in both the regulation of serotonergic neurotransmission and the mechanism of action of many antidepressant drugs. In this study, variability in the SERT gene was analyzed for the first time in a sample of patients with major depression with melancholia (MDDM) in the context of a genetic association study. Two different polymorphisms of the SERT gene (17q11.1-17q12) were analyzed: a variable number of tandem repeats (VNTR) polymorphism in intron 2, and a deletion/insertion polymorphism (5-HTTLPR) in the promoter region of the gene, the short variant of which (allele 484) reduces the transcriptional efficiency of the SERT gene. Our sample consisted of 74 unrelated subjects who strictly met DSM-IV criteria for MDDM and 84 healthy controls, all of Spanish origin. The analysis of haplotype distribution for both polymorphisms showed significant differences between cases and controls (log-likelihood ratio chi2=11.15, df=4, P=0.025). Moreover, when the frequencies of the 484-STin2.10 haplotype were considered in comparison with any other haplotype combination, a significant increase in this haplotype was found in patients with MDDM [z=2.53 (95% CI, 1.21-5.34), P=0.007]. According to these results, variability in the SERT gene has a small effect on liability to MDDM. Our findings are compatible with an additive effect of both the 484 low-activity allele and a mutation elsewhere within the transporter gene or a susceptibility locus nearby in linkage disequilibrium with the VNTR marker.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9799087     DOI: 10.1007/s004390050823

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  16 in total

Review 1.  Pharmacogenetics of antidepressant response.

Authors:  Stefano Porcelli; Antonio Drago; Chiara Fabbri; Sara Gibiino; Raffaella Calati; Alessandro Serretti
Journal:  J Psychiatry Neurosci       Date:  2011-03       Impact factor: 6.186

2.  Molecular epidemiology of major depressive disorder.

Authors:  Chikako Kiyohara; Kouichi Yoshimasu
Journal:  Environ Health Prev Med       Date:  2009-01-20       Impact factor: 3.674

3.  The "S" Allele of the Serotonin Transporter Is Not Associated with Major Depression in a Sample OF Veterans.

Authors:  Jack R Cornelius; Gretchen L Haas; Gerald Goldstein; Barbara Hanusa; Jon D Walker; Lauren J Fox; James Ferrell
Journal:  Adv Genet Res       Date:  2014

4.  The "S" Allele of the Serotonin Transporter Is Not Associated with Major Depression or Alcohol Use Disorders in a Veteran Sample.

Authors:  Jack R Cornelius; Gretchen L Haas; Gerald Goldstein; Barbara Hanusa; Jon D Walker; Lauren J Fox; Dennis Daley; Antoine Douaihy; Gloria Klima; James Ferrell
Journal:  Int J Med Biol Front       Date:  2014

5.  The risk for major depression conferred by childhood maltreatment is multiplied by BDNF and SERT genetic vulnerability: a replication study.

Authors:  Blanca Gutiérrez; Juan Á Bellón; Margarita Rivera; Esther Molina; Michael King; Louise Marston; Francisco Torres-González; Berta Moreno-Küstner; Patricia Moreno-Peral; Emma Motrico; Carmen Montón-Franco; María J GildeGómez-Barragán; Marta Sánchez-Celaya; Miguel Á Díaz-Barreiros; Catalina Vicens; Juan de Dios Luna; Irwin Nazareth; Jorge Cervilla
Journal:  J Psychiatry Neurosci       Date:  2015-05       Impact factor: 6.186

6.  Common genetic and environmental influences on major depressive disorder and conduct disorder.

Authors:  Anjali Subbarao; Soo Hyun Rhee; Susan E Young; Marissa A Ehringer; Robin P Corley; John K Hewitt
Journal:  J Abnorm Child Psychol       Date:  2007-10-27

7.  SLC6A4 polymorphisms and age of onset in late-life depression on treatment outcomes with citalopram: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report.

Authors:  Paulo R Shiroma; Maureen S Drews; Jennifer R Geske; David A Mrazek
Journal:  Am J Geriatr Psychiatry       Date:  2013-08-20       Impact factor: 4.105

8.  Serotonin transporter gene polymorphisms & obsessive-compulsive disorder.

Authors:  Humberto Nicolini
Journal:  Indian J Med Res       Date:  2010-12       Impact factor: 2.375

9.  Serotonin transporter gene polymorphism and treatment response to serotonin reuptake inhibitor (escitalopram) in depression: An open pilot study.

Authors:  Mushtaq A Margoob; Dhuha Mushtaq; Imtiyaz Murtza; Huda Mushtaq; Arif Ali
Journal:  Indian J Psychiatry       Date:  2008-01       Impact factor: 1.759

10.  The serotonin transporter gene polymorphism (SLC6A4) and risk for psychiatric morbidity and comorbidity in the Baltimore ECA follow-up study.

Authors:  Ruben Miozzo; William W Eaton; O Joseph Bienvenu; Jack Samuels; Gerald Nestadt
Journal:  Compr Psychiatry       Date:  2020-08-12       Impact factor: 3.735

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.